The future of dbSNP in toxicology is promising, with advances in genomics and bioinformatics enhancing its utility. As sequencing technologies become more accessible, the expansion of dbSNP will provide deeper insights into the genetic basis of toxicological responses. This will improve risk assessment models and foster the development of safer chemicals and drugs tailored to genetic profiles.
